[HTML][HTML] Next-Generation Sequencing Reveals a High Frequency of HIV-1 Minority Variants and an Expanded Drug Resistance Profile among Individuals on First-Line …
M Nannyonjo, J Omooja, DL Bugembe, N Bbosa… - Viruses, 2024 - mdpi.com
We assessed the performance and clinical relevance of Illumina MiSeq next-generation
sequencing (NGS) for HIV-1 genotyping compared with Sanger sequencing (SS). We …
sequencing (NGS) for HIV-1 genotyping compared with Sanger sequencing (SS). We …
Next Generation Sequencing Reveals a High Prevalence of HIV-1 Minority Variants and an Expanded Drug Resistance Profile Among Individuals Initiated to …
M Nannyonjo, J Omooja, DL Bugembe, N Bbosa… - 2023 - researchsquare.com
Methods In this retrospective case-control study, 167 people with matched Sanger
sequencing data underwent HIV genotypic analysis using an Illumina-Miseq. These …
sequencing data underwent HIV genotypic analysis using an Illumina-Miseq. These …
[PDF][PDF] Prevalence of minority Human Immunodeficiency virus multi-drug resistant mutations among patients failing a Nucleoside Reverse Transcriptase Inhibitor …
IL Nankya, E Nabulime, F Kyeyune, CM Kityo… - 2021 - academia.edu
Prevalence of minority Human Immunode ciency virus multi-drug resistant mutations among
patients failing a Nucleoside Reverse Tr Page 1 Page 1/25 Prevalence of minority Human …
patients failing a Nucleoside Reverse Tr Page 1 Page 1/25 Prevalence of minority Human …